Skip to main content

PharmacoEconomics - Open

Ausgabe 1/2025

Inhalt (14 Artikel)

Acknowledgement to Referees

  • Open Access
  • Acknowledgement to Referees

Costs of Illness for Huntington’s Disease: A Systematic Review

  • Open Access
  • Systematic Review

Divya Patil, Emily F. Gorman, T. Joseph Mattingly II

Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis

  • Open Access
  • Original Research Article

Wendy I. Sligl, Charles Yan, Jeff Round, Xiaoming Wang, Justin Z. Chen, Cheyanne Boehm, Karen Fong, Katelynn Crick, Míriam Garrido Clua, Cassidy Codan, Tanis C. Dingle, Connie Prosser, Guanmin Chen, Alena Tse-Chang, Daniel Garros, David Zygun, Dawn Opgenorth, John M. Conly, Christopher J. Doig, Vincent I. Lau, Sean M. Bagshaw

Digital Versus Paper-Based Consent from the UK NHS Perspective: A Micro-costing Analysis

  • Open Access
  • Original Research Article

Rachel Houten, Mohammad Iqbal Hussain, Antony P. Martin, Nick Ainsworth, Claudia Lameirinhas, Alexander W. Coombs, Simon Toh, Christopher Rao, Edward St John

Cost Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada: An Analysis Using Real-World Evidence from the EVOLVE Study

  • Open Access
  • Original Research Article

Aren Fischer, Stephen Mac, Erica Stivelman Freiman, John K. Marshall, Kim Rand, Juan M. Ramos-Goñi

Healthcare Resource Utilization and Associated Costs During the First 5 Years After Diagnosis and at the End of Life: A Nationwide Cohort Study of Patients with Multiple Myeloma in Finland

  • Open Access
  • Original Research Article

Mikko Kosunen, Jarno Ruotsalainen, Alvar Kallio, Roope Metsä, Paavo Raittinen, Leena Lehmus, Maarit J. Korhonen, Timo Purmonen

Cost-Utility and Budget Impact Analysis of Adding SGLT-2 Inhibitors to Standard Treatment in Type 2 Diabetes Patients with Heart Failure: Utilizing National Database Insights from Thailand

  • Open Access
  • Original Research Article

Tanawan Kongmalai, Juthamas Prawjaeng, Phorntida Hadnorntun, Pattara Leelahavarong, Usa Chaikledkaew, Ammarin Thakkinstian, Varalak Srinonprasert

Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis

  • Open Access
  • Original Research Article

Zheng-Yi Zhou, Mark E. Bensink, Nisha C. Hazra, Chunyi Xu, Bruce Hendry, Claire C. Sharpe, Mo Zhou

Cost-Effectiveness of Fruquintinib for Refractory Metastatic Colorectal Cancer in the USA

  • Open Access
  • Original Research Article

Dong-Won Kang, Patricio B. Lynn, Li Wang, Shouhao Zhou, Chan Shen

CMS’s Drug Price Negotiation Program 2023 Patient-Focused Listening Sessions: A Descriptive Analysis of Speaker Remarks

  • Open Access
  • Original Research Article

Julie A. Patterson, Tyler D. Wagner, Rayan K. Salih, Gabri’el D. Shabazz, Jonathan D. Campbell

Mortality, Clinical Complications, and Healthcare Resource Utilization Associated with Managing Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-occlusive Crises in Italy

  • Open Access
  • Original Research Article

Chuka Udeze, Melania Dovizio, Chiara Veronesi, Luca Degli Esposti, Nanxin Li, Thi Xuan Mai Patricia Dang, Gian Luca Forni

Costs of Adverse Events in Patients with Advanced or Metastatic Renal Cell Carcinoma with First-Line Treatment

  • Open Access
  • Original Research Article

Yan Chen, Ella X. Du, Manasvi Sundar, Keith A. Betts, Xin Yin, Samantha Eiffert, Karen Beauchamp, Andrew Delgado, Lisa Rosenblatt

Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years

  • Open Access
  • Original Research Article

Eline H. Ploumen, Martijn J. Oude Wolcherink, Rosaly A. Buiten, Tineke H. Pinxterhuis, Carine J. M. Doggen, Carl E. Schotborgh, Peter W. Danse, Martijn Scholte, K. Gert van Houwelingen, Paolo Zocca, Xavier G. L. V. Pouwels, Clemens von Birgelen

Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing

  • Open Access
  • Protocol

Mussab Fagery, Hadi A. Khorshidi, Stephen Q. Wong, Özge Karanfil, Jon Emery, Maarten J. IJzerman